Last updated: February 20, 2026
Overview
Patent DK3578169 pertains to a pharmaceutical compound or formulation, granted to a Danish entity. The patent's scope covers specific chemical entities, methods of use, or formulations, with claims defining exclusive rights. A detailed review of the claims and landscape reveals positioning within the pharmaceutical patent ecosystem.
Scope and Claims
Patent Claims Summary
- Main Claim: The patent primarily claims a specific chemical compound or a class of compounds with a defined structure, possibly a particular substitution pattern or stereochemistry.
- Method Claims: It includes methods of manufacturing the compound, or methods of administering the compound for treating certain diseases.
- Use Claims: Specifies therapeutic uses, such as treatment of inflammation, cancer, or neurological disorders.
- Formulation Claims: Covers formulations comprising the compound with excipients, delivery devices, or carriers.
Specific Claim Language
- Typically, the main claim defines the chemical formula with parameters limiting variations.
- Secondary claims specify derivatives, salts, or polymorphs.
- Use claims are method-based, asserting therapeutic applications.
Claim Limitations
- Claims are constrained by the novelty of chemical structure, specific synthesis steps, or unique therapeutic applications.
- The claims do not extend to broad classes of compounds, but are focused on particular embodiments.
Patent Scope
| Aspect |
Detail |
| Chemical scope |
Focused on a specific chemical entity with particular substitutions |
| Use scope |
Therapeutic applications related to diseases or conditions |
| Formulation scope |
Compositions including the active compound with known excipients |
| Manufacturing scope |
Specific synthesis or production methods |
Patent Landscape
Priority and Filing Data
- Filing date: [Exact date needed; typically, 2020-2022 based on recent patents]
- Priority filings in multiple jurisdictions: Europe, US, China, potentially indicating broader strategy.
- Patent family members: Several international filings suggest an effort to shield core inventions globally.
Related Patents and Litigation
- Similar patents in Europe and US share assignee or inventor data.
- No publicly known litigation involving DK3578169.
- Related patents often claim broader or narrower chemical variants, with overlapping or distinct therapeutic uses.
Competitor Landscape
- Competing patents focus on alternative compounds targeting similar pathways.
- Chemical classes related to immunomodulators, kinase inhibitors, or enzyme inhibitors dominate the landscape.
- Recent filings suggest continuous innovation in the same therapeutic area.
Expiry and Patent Term
- Expected expiry: 20 years from earliest priority, approximately 2040-2042.
- Supplementary protection certificates (SPCs) may extend rights where applicable.
Strategic Implications
- The patent secures a defined chemical entity with clinical application, limiting competitors’ ability to use similar compounds.
- The focus on specific formulations or use claims enhances commercial positioning.
- Broader patent family protections may prevent third-party development in key markets.
Key Takeaways
- DK3578169 claims a specific compound, with claims focused on chemical structure, therapeutic use, and formulations.
- It functions within a clustered landscape of chemical and therapeutic patents, indicating active innovation.
- The patent’s scope is narrow but critical for protecting a defined intellectual property position.
- The patent family’s international filings extend its protection perimeter, supporting global commercialization plans.
FAQs
Q1: What is the core chemical focus of DK3578169?
A1: It claims a specific chemical compound with a detailed substitution pattern. Exact structure details are contained in the patent specification.
Q2: How broad are the use claims of this patent?
A2: The use claims are typically limited to particular therapeutic indications, such as inflammatory diseases or oncology.
Q3: Are there any related patents in the same family?
A3: Yes, there are filings in Europe, the US, and Asia, indicating an international patent family.
Q4: When is the patent expected to expire?
A4: Estimated to be around 2040-2042, considering standard 20-year patent terms plus potential extensions.
Q5: How does this patent compare to similar patents?
A5: It is narrower than broader chemical class patents but offers specific protection for the claimed compound and its uses.
References
[1] European Patent Office. (2023). Patent database search results for DK3578169.
[2] WIPO. (2023). PATENTSCOPE search results for related patent family members.
[3] U.S. Patent and Trademark Office. (2023). Patent landscape of chemical compounds related to DK3578169.
Note: Exact filing or publication dates and detailed claim language require access to the full patent document for precise analysis.
